Cellular breakdown in lung therapy changes in light of the malignant growth type and stage. Normal choices incorporate a medical procedure to eliminate growths, chemotherapy to target disease cells, and radiation treatment for restricted control. Designated treatments and immunotherapies have arisen as inventive methodologies, improving endurance rates. Viable lung cancer treatment requires a customized plan.